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under iron limitation highlights the versatility of the P. aeruginosa in multitasking its regulatory As an inducible system, it is strictly regulated to avoid the metabolic burden due to its 86 constitutive expression and autoimmunity (20) (21, 22) . The CRISPR-Cas systems in bacteria are 87 regulated in response to population dynamics and environmental factors such as Quorum 88
Sensing, glucose availability, temperature(23)(21)(15)(24)(25). These factors are known to 89 predispose the bacteria to phage infection and also influence their ability to defend against 90 phage infection via the CRISPR-Cas system. 91 92 Bacteria encounter various biotic and abiotic stress factors in the external environment and 93 host that make them vulnerable to phage infection. Here we show an iron-dependent 94 regulation of the type I-F CRISPR-Cas system via the ECF sigma factor, PvdS in P. aeruginosa. 95
This regulatory pathway of the CRISPR-Cas system by PvdS in response to iron limitation 96 highlights the ability of P. aeruginosa to adapt by evolving contingency pathways under 97 conditions when it is most vulnerable to phage infection. 98 6 fusion construct (PmePcas1-lacZ) ( Fig. 1A ). Using this construct, transposon mutants with 108 reduced cas1 expression were visually inspected and selected for -galactosidase analysis. 109
White colonies were due to transposons inserted in the construct and were not selected for 110 further analysis. Following the visual inspection, we identified several transposon mutants 111 exhibiting less blue coloration compared to the wild type. Transposon insertion site mapping 112 revealed several genes, with a notable one encoding the ECF sigma factor, PvdS located 113 upstream of the CRISPR-Cas genes (Fig. 1A) . Since PvdS is activated under iron-depleted 114 conditions, we adapted the iron-depleted media, LB + 2,2-dipyridyl (LB+2,2DP) (26)(8) to study 115 its regulatory effect on the CRISPR-Cas system. Growth analysis of the strains in LB and 116 LB+2,2DP showed that the latter supports the growth of pvdS mutants (Fig. S1 ), therefore this 117 media was used for our downstream analysis. Despite the minor growth defect of pvdS mutant 118 under iron-depleted conditions compared to the wild type ( Fig. S1 ), it was not sufficient to 119 influence the expression of the CRISPR-Cas system. In the wild type background expression of 120 the cas1 was upregulated under iron-depleted conditions compared to the normal conditions 121 (LB) (Fig. 1B) . Furthermore, expression of the cas1 was significantly reduced in the pvdS mutant 122 whereas deletion of pvdS did not effect cas gene expression under normal conditions ( Fig. 1B) . 123
Additionally, the expression of the cas gene in the pvdS mutant was rescued when we 124 complemented pvdS in trans under iron-depleted conditions (Fig. S1B ). In general, the 125 expression of the cas genes was upregulated under iron-depleted conditions compared to 126 normal condition ( fig S1C) . 127 7
The expression of pvdS is repressed by Fur when iron is abundant in the environment thus, 129 resulting in the downregulation of the PvdS-regulated genes. However, under iron-depleted 130 conditions, Fur relieves PvdS, allowing it to bind to the consensus binding sites in the promoter 131 region of genes and inducing their expression (26). To investigate whether Fur influences the 132 PvdS-CRISPR-Cas regulation, we analyzed the expression of the cas genes in the fur and pvdS 133 mutants under iron-depleted and normal conditions. In the fur mutant expression of the cas 134 genes were upregulated under both normal and iron-depleted conditions relative to the wild 135 type ( Fig. S2A and S2B ). This was contrary to the expression of cas genes in the pvdS mutants as 136 they were downregulated under iron-depleted condition ( Fig S2A) . This shows that the deletion 137 of fur derepressed the pvdS even under normal conditions and therefore allows PvdS to 138 regulate the cas genes. This is in agreement with the Fur-PvdS regulatory system shown by 139 previous studies (5)(27)(28). From our analysis, exogenous pyoverdine (PVD) did not 140 significantly increase cas gene expression in both wild type and pvdS mutant (Fig. 1C ), which 141 signifies the possibility that PvdS regulation of the CRISPR-Cas system may be independent of 142 siderophore production and uptake. 143 144 PvdS binding site in cas1 promoter is required for CRISPR-Cas regulation 145 146 PvdS directly regulates its target genes by interacting with a consensus binding site in their 147 promoter region. This interaction and regulation are facilitated by the formation of a complex 148 with Core RNA polymerase (cRNAP)(26). The examination of the cas1 promoter region revealed 149 the presence of two PvdS binding sites (Fig 2A) . To investigate whether the predicted PvdS binding site are required for interaction and regulation of the cas genes, we created an 151 integrative cas1 promoter-lacZ reporter strain with altered PvdS binding site sequence and 152 examined the effect on cas1 expression under iron-depleted conditions ( Fig 2B) . Initially, we 153 investigated the effect of the mutations on the interaction between PvdS and PvdS-cRNAP 154 complex with the cas1 promoter region. The binding assay revealed that the mutation of one 155 binding site did not affect the interaction between PvdS-cRNAP and the cas1 promoter region 156 was more significant when we altered both binding sites in the wild type PA14 compared to the 164 single binding alteration in the wild type background ( Fig 3A) . Additionally, alteration of single 165 PvdS binding sites resulted in similar expression as the intact sequence in the pvdS mutant 166 background ( Fig. 3) . These results show that PvdS interaction with a consensus binding site in 167 the promoter region of cas1 is required for cas gene expression. Since PvdS is known to require 168 multiple sites for full activity in vivo and in vitro (26), the decrease in cas gene expression as a 169 result of mutations in the binding sites may imply the requirement of both sites for optimal 170 regulation by PvdS. 171
PvdS influences CRISPR-Cas interference of horizontal gene transfer and adaptation 173
Since PvdS regulates the cas genes expression under iron-depleted condition, we further 175 investigated how this regulation influences the function of the CRISPR-Cas system in interfering 176 with HGT and the acquisition of spacers from the foreign nucleic acid. Acquisition of spacers is 177 required for the development of immunological memory against specific nucleic acid sequences 178 (29). To test the impact of PvdS on the interference and adaptation of the CRISPR-Cas system, 179
we engineered CRISPR-targeted constructs containing sequences similar to CRISPR 2 spacer 1 of 180 the type I-F CRISPR-Cas system in PA14. In the three constructs designed, pUCPTsp1 contained 181 matching sequences to CRISPR 2 spacer while pUCPTSp2n and pUCPTSp4n contained 2 and 4 182 nucleotide substitutions respectively after the GG PAM sequence recognized the Type I-F 183 CRISPR-Cas system. These mutations in the protospacer reduce interference but can initiate 184 primed adaptation (21)(15). The naïve plasmid used lacked the protospacer and the consensus 185 GG PAM sequence. 186
We initially quantified the retention of the naïve and the CRISPR-targeted (pUCPTSp1) plasmid 187 transferred into the pvdS mutant and the wild type PA14 under iron-depleted and normal 188 conditions ( fig 4) . Retention of the CRISPR-targeted plasmid was significantly reduced in the 189 wild type compared to the pvdS mutant when passaged over five days in the iron-depleted 190 media ( Fig. 4A ). As expected, there was no significant loss of the naïve plasmid when 191 transferred in both the wild type and pvdS mutant after passage over five days in both normal 192 conditions and iron-limited conditions ( Fig. S5A and S5B ). However, under normal conditions, 193 the wild type and pvdS mutant exhibited similar levels of CRISPR-Cas targeted-plasmid loss (Fig. 194 4B). These results show that PvdS is required for the induction of the CRISPR-Cas plasmid 195 interference under iron-depleted conditions. 196 197 Additionally, we investigated the influence of PvdS on CRISPR-Cas spacer acquisition which is 198 depicted by an expansion of the CRISPR2 array. We targeted the CRISPR2 which has been 199 previously shown to have a higher adaptation frequency in P. aeruginosa (20)(15). The P. 200 aeruginosa wild type PA14, pvdS and cas3 mutants containing CRISPR-Cas targeted plasmids 201 (pUCPTSp1, pUCPTSp2n, and pUCPTSp4n) were passaged for five days in both iron-depleted 202 and normal media. Three successive adaptation assays were performed in the strains to test 203 the versatility of the P. aeruginosa CRISPR-Cas system to incorporate multiple spacers into its 204 array. As expected, deletion of cas3 resulted in no expansion of the CRISPR2 array under both 205 iron-depleted and normal conditions compared to the wild type ( Fig. 5A ). Also, a significantly 206 lower expansion (~60% less than wild type) of the CRISPR2 array was detected in the pvdS 207 mutants compared to the wild type under iron-depleted conditions. However, there were no 208 significant differences in spacer acquisition observed under normal conditions between the wild 209 type and the pvdS mutant ( Fig. 5A ). 210
Next, we examined the influence of PvdS on the CRISPR-Cas system in eliminating incoming 211 nucleic acid sequences to which it has previously encountered. For this assay, we determined 212 the efficiency of conjugal transfer of CRISPR-targeted plasmid (pUCPTSp1) and non-targeted 213 plasmid (pUCPT) from E. coli S17 to P. aeruginosa strains. From this assay the conjugation 214 efficiency of the targeted vs the untargeted plasmid significantly increased ~3-fold in the pvdS 215 influences CRISPR-Cas targeted plasmid interference (Fig. 5B ). The pvdS mutant exhibited a 217 similar increase in conjugation efficiency when compared under both iron-depleted and normal 218 conditions (~3fold increase). However, under normal conditions, there was no difference in the 219 conjugation efficiency between the wild type and the pvdS mutant. As expected, cas3 mutation 220 resulted in a similar effect on conjugal plasmid transfer under both iron-depleted and normal 221 conditions ( Fig. 5B ). Therefore, it can be implied that PvdS regulation of the cas genes 222 influences the ability of the CRISPR-Cas system to interfere with horizontal gene transfer under 223 iron-depleted conditions. 224
225
Discussion 226 227 Pseudomonas aeruginosa is characterized as a metabolically versatile bacteria capable of 228 adapting to various biotic and abiotic stress factors in its environment by altering its regulatory 229 systems. In this study, we highlight the ability of P. aeruginosa to multitask its regulatory 230 system for adapting and thriving under iron-depleted conditions and defending against 231 deleterious effects of horizontal gene transfer. P aeruginosa engages the ECF sigma factor, PvdS 232 to regulate the CRISPR-Cas system under iron-depleted conditions (10)(11)(12). We show that 233 iron limitation increases the cas gene expression ( Fig. 1) as well as the CRISPR-Cas mediated 234 plasmid interference and spacer acquisition (Fig. 5 ). The PvdS-CRISPR-Cas regulatory system 235 under iron-depleted conditions, presents a well-coordinated response and an alternative 236 defense mechanism against phage infection and HGT. This study further adds to the expanding 237 regulatory spectrum of the CRISPR-Cas system in responding to environmental factors and the 238 ability of bacteria to evolve defense mechanisms for survival under biotic and abiotic stress 239 conditions. 240 241 Previous studies have shown the regulation of the CRISPR-Cas system by metabolite sensing 242 pathways, temperature, membrane stress, oxidative stress and Quorum Sensing 243 (23)(21)(15)(24)(25). This work further adds to previous findings indicating the induction of 244 CRISPR-Cas expression under stress conditions compared with normal conditions (20) (23) . 245
Bacteria constantly evolve mechanisms to adapt to stress conditions in their environments, 246 such as iron limitation. Bacteriophages are ubiquitous and their infection commonly requires 247 prior attachment to specific receptors followed by transfer of their nucleic acids into the cell. 248
Iron limitation induces the expression of iron transport channels (30)(31), which can serve as 249 phage attachment sites and entry channels for nucleic acids (10)(11)(12). Hence the evolution 250 of the regulatory system for the CRISPR-Cas system to defend bacteria under such conditions is 251 a vital adaptive mechanism. As an adaptive immune system, expression of the CRISPR-Cas 252 system is known to be metabolically costly to the bacteria (20)(32), Therefore, selective 253 induction of the system under stress condition such as iron depletion, where the bacteria are 254 most vulnerable to phage attack is more beneficial to the bacteria. As such expression of the 255 cas genes is indirectly repressed by fur via the PvdS under normal conditions ( Fig S3) . This also 256 reduces the risk of autoimmunity imposed by constitutive expression of the system. 257
258
In an era where increased resistance to antibiotics is on the rise, alternative therapies are being 259 experimented for the effective treatment of pseudomonas infections. The use of phage therapy for the treatment of bacterial infections seems like a plausible venture (33). TonB-dependent 261 siderophore uptake systems also serve as targets for antibiotics (34). The development of the 262 trojan horse approach (9) which targets the siderophore transport channels to increase 263 susceptibility to drugs and reduce resistance gene acquisition presents a good platform for a 264 possible combinatory strategy with phage therapy. As seen with antibiotic therapy, bacteria 265 continuously evolve resistance mechanisms against harmful agents. The CRISPR-Cas system 266 remains a potent defense mechanism for bacteria and thus to develop effective phage therapy, 267 targeting a key regulator such as PvdS may present a promising approach to downregulate the 268 phage defense system and prevent resistance during phage therapy. 269
270

Experimental procedures 271 272
Strains, plasmids and media conditions 273
The bacterial strains, plasmids, and oligonucleotides used in this study are listed in Table S1 and 274 S2. P aeruginosa UCBPP-PA14 designated in this study as PA14 was used as the wild type strain. aeruginosa strains when required. When needed minimal media was supplemented with 280 gentamicin (30g/mL) and sucrose (10% w/v). Bacterial growth media were supplemented with 281 antibiotics at the following concentrations: tetracycline, 10 g/ml for E. coli and 50 g/ml for P. aeruginosa; carbenicillin 200g/ml for E. coli and 300g/ml for P. aeruginosa; kanamycin, 283 50g/ml for E. coli. X-gal was added at a concentration of 50g/ml. 284
The pUCPT, a derivative of pUCP19 containing oriT fragment from pK18, which allows for 285 effective conjugal transfer from E. coli to P. aeruginosa was used to design the CRISPR-Cas 286 targeted constructs. CRISPR-Cas targeted constructs pUCPTSp2n and pUCPTSp4n respectively 287 were created by inserting the CRISPR 2 spacer1 fragments with 2 and 4 nucleotide substitutions 288 adjacent to the GG PAM sequence , into the HindIII/EcoRI digested pUCPT. Sequences were 289 verified by PCR and sequencing using the M13 forward and M13 reverse primers. The Mariner 290 transposon, pBT20 which confers gentamicin resistance was used for random transposon 291 mutagenesis to screening for regulators of the Type I-F CRISPR-Cas system. The plasmid 292 pK18mobsacB with the gentamicin resistance cassette was used to design constructs for in-293 frame deletion and chromosomal lacZ integration. 294
In-frame deletion and integrative Pcas1-lacZ reporter construction 295
To create in-frame deletion mutants in P. aeruginosa strains, Upstream and Downstream DNA 296 fragments flanking the region of interest in the genome were amplified by PCR using primers 297 listed in Table S2 and ligated with the EcoRI/HindIII digested suicide vector pK18mobsacB using 298 the MultiS cloning kit (Vazyme, China). The ligation products were transformed into E. Coli 299 DH5 and positive colonies selected by blue/white screening on gentamicin (5g/mL) and X-gal 300 selection plates and verified by colony PCR and DNA sequencing. Selected constructs were 301 transformed into E. Coli S17-1 for conjugation with P. aeruginosa strains. Transconjugants 302 were selected on Minimal medium containing gentamicin (30g/mL), followed by the selection 303 of in-frame deletion mutants on MM supplemented with sucrose (10% w/v). Mutants were 304 further confirmed by PCR and DNA sequencing. 305
Transposon mutagenesis 306
The Mariner transposon, pBT20 was transferred from E. coli S17 to P. aeruginosa PA14 307 (pMEPcas1-lacZ ) strains by conjugation. Aliquots (10 -3 ) of the mating mix were spread on MM 308 agar (1.5% w/v) supplemented with Tetracycline (50 g/ml) and 5-bromo-4-chloro-3-indoyl-D-309 galactopyranoside(X-gal)(50 g/ml). Single colonies of the transconjugants were picked onto 310 the selection plate composed of MM agar (1.5% w/v) and X-gal (50 g/ml). Plates were 311 incubated for 48 hours and transposon mutants visually inspected for altered blue coloration 312 due to the up/downregulation of the Pcas1-lacZ activity in comparison to the wild type. 313
Colonies with altered coloration were selected tail colony PCR and DNA sequencing using 314 primers in Table S2 . We screened over 5000 colonies on the selective media plates. Transposon 315 insertion site mapping was achieved after BLAST search of the sequences against the P. 316 aeruginosa genome (www.pseudomonas.com).
PvdS protein expression and purification. 324
The vector pET-28b(+) (Novagen) was used for the expression of PvdS. The coding sequences of 325 PvdS were amplified using the primer pairs listed in Table 2 . The generated DNA fragments 326 were ligated with the pET-28b(+) resulting in the fusion of the gene to the sequence encoding 327 C-terminal His-tag. The resulting constructs, confirmed by sequencing, was transformed into E. 328 coli BL21(DE3). E. coli BL21(DE3) colony carrying pET-PvdS was grown in LB broth supplemented 329 with kanamycin at 37 o C to OD 600 = 0.5 and subsequently induced with isopropyl β-D-330 thiogalactoside (IPTG) (0.1 mM) at 16 o C overnight. After overnight incubation, cells were 331 harvested by centrifugation and bacterial pellets resuspended in cold lysis buffer (50 mM 332 NaH 2 PO4, 300 mM NaCl, 1 mM DTT, 10 mM imidazole, pH 7.5) containing protease inhibitors 333 (Complete mini, EDTA free, Roche) and lysed by sonification. The Cell-free supernatants were 334 obtained by high-speed centrifugation, the supernatant was incubated with ProteinIso Ni-NTA 335
Resin (TransGene Biotech, China) at 4 °C for 2 h. The column was washed 3-4 times with wash 336 buffer (50 mM NaH 2 PO4, 300 mM NaCl, 1 mM DTT, 50 mM imidazole, pH 7.5) and eluted with 337 the elution buffer (50 mM NaH 2 PO4, 300 mM NaCl, 1 mM DTT, 300 mM imidazole, pH 7.5). The 338 protein purity was determined by SDS-PAGE analysis and dialyzed against the PBS buffer (PBS, 5% 339 glycerol, pH 7.4) at 4 °C. 340
Electromobility Shift Assay (EMSA) 341
The DNA fragments were generated by PCR using the indicated primers in Table S2 and end  342 labeled with biotin using the biotin 3 I end DNA-labeling kit (thermo scientific) as described in 343 the kit protocol. EMSAs were performed using the LightShift chemiluminescent EMSA kit (Thermo scientific) according to the kit protocol. Briefly, 1nm of DNA fragments were incubated 345 with cRNAP-PvdS or PvdS and the binding buffer containing 1μg/μl Poly (dI.dC), 50% Glycerol, 1% 346 NP-40 1M KCl 100mM MgCl 2 and 200mM EDTA supplied with the kit for 25 minutes at 25 o C. 347
The cRNAP was added at a concentration of 1nM. The samples were then resolved on 6% native 348 polyacrylamide gel in 0.5X TBE buffer and transferred to the nylon membrane at 380mA (~100V) 349 for 30 minutes. DNA was crosslinked at 120mJ/cm2 for 45-60 seconds followed by detection of 350 the biotin-labeled DNA by chemiluminescence using the Tanon 5200 imaging system. 351
Plasmid loss and spacer acquisition 352
The plasmids pUCPT (non-targeted naïve control), pUCPTSp2n and pUCPTSp4n (2 and 4 353 nucleotide substitutions in respectively) were transferred into P. aeruginosa strains via 354 conjugation with E. coli S17. Selected colonies were cultured overnight in 5 ml LB with or 355 without 2,2-DP and passaged for 5 days by a subculture of 20l into 5 ml fresh media. Each 356 passage was serially diluted and 10 -6 dilutions plated on LB with or without carbenicillin to 357 count colonies that retain the plasmid. P. aeruginosa strains initially passaged with pUCPTSp2n 358 were further transformed with pUCPTSp4n and passaged for 5 days to assay for primed 359 adaptation. The genomic DNA was then extracted for the identification of expanded CRISPR2 360 arrays using primers stated in Table S2 . PCR products were resolved by 3% agarose gel 361 electrophoresis for detection of the CRISPR array expansion. E. coli S17 was used to transfer CRISPR-targeted pUCPTSp1 (pUCPT containing CRISPR2 364 spacer1) and untargeted pUCPT into P. aeruginosa strains. Overnight culture of E. coli and P. 365 aeruginosa were mixed at a ratio of 1:1, washed twice and pellets resuspended in LB from 366 which 50l was spotted on LB agar gently to prevent splatter. The mating spot was allowed to 367 dry and incubated for 16 hours at 37 0 C. The mating spot was scrapped completely and 368 resuspended in 250 l TSB from which serial dilutions of 10 -5 were platted on LB and LB+2,2-DP 369 agar with carbenicillin. The efficiency was calculated as the percentage transformants with the 370 targeted plasmid compared with the transformants with the non-targeted plasmid. 
